Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BICYCLE THERAPEUTICS PLC Director's Dealing 2021

Jan 5, 2021

32777_dirs_2021-01-05_b121a8be-2216-40fe-877e-0377eadf8fe3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2021-01-04

Reporting Person: Legault Pierre (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-01-04 Stock Option (right to buy) $17.95 A 38000 Acquired 2031-01-04 Ordinary Shares (38000) Direct